- Home
- MGLD vs SRTS Comparison
MGLD vs SRTS Comparison
Compare MGLD & SRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MGLD | SRTS |
|---|---|---|
| Founded | 1996 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 44.8M | 45.6M |
| IPO Year | 2021 | 2016 |
Fundamental Metrics
Financial Performance| Metric | MGLD | SRTS |
|---|---|---|
| Price | $1.97 | $2.85 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $5.38 |
| AVG Volume (30 Days) | ★ 396.2K | 17.6K |
| Earning Date | 11-05-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 28.57 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $34,876,734.00 | $27,482,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $41.11 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.84 | $2.66 |
| 52 Week High | $2.12 | $5.49 |
Technical Indicators
Market Signals| Indicator | MGLD | SRTS |
|---|---|---|
| Relative Strength Index (RSI) | 76.37 | 52.81 |
| Support Level | $0.92 | $2.97 |
| Resistance Level | $2.12 | $3.17 |
| Average True Range (ATR) | 0.02 | 0.13 |
| MACD | -0.04 | 0.01 |
| Stochastic Oscillator | 9.00 | 76.47 |
Price Performance
Historical ComparisonAbout MGLD The Marygold Companies Inc.
The Marygold Companies Inc is an international holding company focused on acquiring and growing profitable businesses. Its main segments include U.S. Fund Management through USCF Investments, Food Products via Gourmet Foods and Printstock Products in New Zealand, Beauty Products under the Original Sprout brand, and formerly Security Systems through Brigadier, sold in 2025. The majority of revenue comes from fund management. The company operates in the USA, New Zealand, the United Kingdom, and Canada, with the majority of revenue generated from the USA. Its business approach focuses on strengthening financial services, expanding fintech, and managing a diverse portfolio for growth.
About SRTS Sensus Healthcare Inc.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.